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Synthesis of 5R*-(3-methoxy-phenyl)-3,7-dimethyl-5H-thiazolo[3,2-a]pyrimidine-2,6-dicarboxylic acid 
diethyl ester (2a) and 3,7-dimethyl-5S*-thiophen-2-yl-5H-thiazolo[3,2-a]pyrimidine-2,6-dicarboxylic acid 
diethyl ester (2b) are achieved by the cyclocondensation of 3,4-dihydropyrimidine-2-thione derivative with 
α-haloester. Preliminary analysis was done spectroscopically by means of 1H NMR spectra, mass spectra 
and elemental analyses. Further the structures were confirmed by X-ray crystal structure analysis. The two 
molecules are not identical in configuration. In both the compounds the central pyrimidine ring adopts a 
conformation which is best described as an intermediate between a boat and screw boat form. The crystal 
structure is stabilized by intermolecular C–H…O and C–H…π weak interactions. 
DOI: 10.1134/S0022476614080204 
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INTRODUCTION 
Dihydropyrimidines represent a heterocyclic system with remarkable pharmacological efficiency and are described 
as potent mimics of dihydropyridine calcium channel blockers [1-5]. In recent years, several biological activities including 
antiviral, antitumor, antibacterial, and antiinflammatory activities has been ascribed to these partly reduced pyrimidine 
derivatives. More recently, appropriately functionalized DHPMs have emerged as orally active antihypertensive agents [6-8]. 
By performing pharmacological studies with uniquely designed single-enantiomer DHPMs, it was established that calcium 
channel modulation (antagonist versus agonist activity ) is dependent on the absolute configuration at chiral carbon atom, 
whereby the orientation of the aryl group substituted to chiral carbon atom acts as a ″molecular switch″ between antagonist 
(aryl-group up) and agonist (aryl-group down) activity [9]. Furthermore, in the receptor-bound conformation the substituted 
aryl ring should be positioned axially, perpendicular to, and bisecting the boat-like dihydropyridine/pyrimidine ring, with the 
4-aryl substituent preferring the synperiplanar orientation [10]. A cis-carbonyl ester orientation was also found mandatory for 
optimum calcium channel modulators activity. Thus, pyrimidines have been subjected to a large variety of structural 
modifications in order to synthesize derivatives with different biological properties. 
In the course of our structural studies of the family of thiazolopyrimidine derivatives, we report here the structures 
of two such compounds, namely 5R*-(3-methoxy-phenyl)-3,7-dimethyl-5H-thiazolo[3,2-a]pyrimidine-2,6-dicarboxylic acid 
diethyl ester (2a) and 3,7-dimethyl-5S*-thiophen-2-yl-5H-thiazolo[3,2-a]pyrimidine-2,6-dicarboxylic acid diethyl ester (2b). 
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The synthesis of similar derivatives has been reported earlier [11]. The syntheses of these compounds were followed by 
acquisition of their analytical data and subsequent spectroscopic analyses using 1H NMR, mass spectra and elemental 
analysis techniques to confirm the presence of the supposed ring systems, as well as the signals for the existence of various 
protons. Single crystal X-ray diffraction analysis has been carried out for the two compounds in order to establish the crystal 
as well as molecular structure and to understand the self-aggregation in terms of possible intermolecular interactions. 
Molecular packing is controlled by various intermolecular interactions. In the present work we report the synthesis and 
spectroscopic analysis of the two compounds with more emphasis laid on weak interactions. 
EXPERIMENTAL 
All reagents were obtained from commercial sources. Solvents were dried and purified with known conventional 
methods. 
Analytical methods. The melting point was determined in open capillary using Guna melting point apparatus and is 
uncorrected. The IR spectra were recorded as KBr discs using Nicolet FT-IR 410 spectrophotometer. 1H NMR spectra were 
recorded on Varian RXZ-300 MHz spectrometer using TMS as internal reference compound. C, H, N and S were estimated 
in CHNS elementar vario micro cube. Mass spectra were recorded on Finnigan MAT (Model MAT8200) spectrometer. 
Synthesis of the two compounds is as shown in Scheme. 
Procedure for the preparation of 5R*-(3-methoxy-phenyl)-3,7-dimethyl-5H-thiazolo[3,2-a]pyrimidine-2,6-
dicarboxylic acid diethyl ester (2a) and 3,7-Dimethyl-5S*-thiophen-2-yl-5H-thiazolo[3,2-a]pyrimidine-2,6-dicarboxylic 
acid diethyl ester (2b). To a solution of ethylacetoacetate (0.72 mmol) in 2 mL of 1,2 dichloroethane, bromine (0.72 mmol) 
was added slowly with constant stirring, and the mixture was allowed to stir till the solution became colorless. To the above 
colorless solution the compound 1 and triethylamine (0.72 mmol) were added. The reaction mixture was heated to 80 °C with 
vigorous shaking, and heating was continued for 2 h. The solvent was removed under reduced pressure and the residue was 
treated with aqueous sodium bicarbonate solution followed by extraction with ethyl acetate and water, the ethyl acetate layer 
was dried over anhydrous sodium sulphate [12]. Recrystallization from a mixture of methanol and ethyl acetate in 1:1 ratio 
yielded pale yellow crystals of 2a and 2b. Yield 77–81 %. IR showed the absence of a sharp band NH stretching frequency in 
the region of 3200–3400 cm–1. The absence of peak corresponding to two NH groups in 1HNMR spectrum of compounds 
2(a-b) showed the formation of expected product. 
 
 
Scheme. Syntheses of compounds 2a and 2b. 
 
 
Compound 2a. Yield: 81%. M.p: 118–119 °C. IR (KBr νmax, cm
–1): 2977(CH), 1703(C=O), 1600(C=C), 
1496(C=N). 1H NMR (300 MHz, CDCl3): δ 1.29 (t, J = 7.2 Hz, 3H, –CH2CH3), 1.35 (t, J = 7.2 Hz, 3H, –CH2CH3), 2.34 
(s, 3H, CH3), 2.41 (s, 3H, CH3), 3.78 (s, 3H, –OCH3), 4.15 (q, J = 7.2 Hz, 2H, CH2CH3), 4.25 (q, J = 7.2 Hz, 2H, CH2CH3), 
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6.10 (s, 1H, CH), 6.81–7.26 (m, 4H, ArH). % CHNS found (calc): C 60.56(60.32), H 5.81(5.46), N 6.73(7.03), S 7.70 (7.59). 
m/z: 416 (m+), 309 (m-107). 
Compound 2b. Yield: 77%. M.p: 113–114 °C. IR (KBr νmax, cm
–1
): 2976(CH), 1705, 1610(C=O), 
1506(C=N). 
1
H NMR (300 MHz, CDCl3): δ 1.30 (t, J = 7.2 Hz, 3H, –CH2CH3), 1.35 (t, J = 7.2 Hz, 3H, 
–CH2CH3), 2.43(s, 3H, CH3), 2.60 (s, 3H, CH3), 4.21 (q, J = 7.2 Hz, 2H, CH2CH3), 4.29 (q, J = 7.2 Hz, 2H, 
CH2CH3), 6.56 (s, 1H, CH), 6.88–7.26 (m, 3H, ArH). % CHNS found (calc): C 55.08 (55.21), H 5.14 (4.97), 
N 7.14 (7.22), S 16.34 (16.23) m/z: 392 (m+), 319 (m-73). 
X-Ray diffraction analysis. Good quality yellow colored single-crystals of compounds 2a and 2b were obtained by 
slow evaporation from a methanol – ethyl acetate (1:1) mixture. The X-ray diffraction data were collected on a Bruker Smart 
CCD Area Detector System using MoKα (0.71073 Å) radiation for the crystal. The data were reduced using SAINT-Plus [13]. 
The structure was solved by direct methods using SHELXS97 [14] and difference Fourier synthesis using SHELXL97 [14]. 
The positions and anisotropic displacement parameters of all non-hydrogen atoms were included in the full-matrix least-
square refinement using SHELXL97 [14] (Sheldrick, 1997) and the procedures were carried out for a few cycles until 
convergence was reached. The H atoms were placed at calculated positions in the riding model approximation; their 
temperature factors were set to 1.2 times those of the equivalent isotropic temperature factors of the parent atoms. All other 
non-H atoms were refined anisotropically. Molecular diagrams were generated using ORTEP [15]. The mean plane 
calculation was done using the program PARST [16]. 
For the compound 2a, intensity data were collected up to a maximum of 27.00° for the compound in the ω–ϕ scan 
mode. A total of 6245 reflections were collected, resulting in 4347 independent reflections of which the number of reflections 
satisfying I > 2σ(I ) criteria were 3083. These were treated as observed. The R factor after final convergence was 0.0693 and 
the maximum and minimum values of residual electron density were 0.438 and –0.574 e/Å–3. For the compound 2b, intensity 
data were collected up to a maximum of 27.00° for the compound in the ω–ϕ scan mode. A total of 17963 reflections were 
collected, resulting in 4066 independent reflections of which the number of reflections satisfying I > 2σ(I ) criteria were 
2899. These were treated as observed. The R factor after final convergence was 0.0603 and the maximum and minimum 
values of residual electron density were 0.501 e/Å–3 and –0.508 e/Å–3. 
Crystallographic data for the structure 2a and 2b reported in this paper have been deposited with the Cambridge data 
centre. The deposition numbers are CCDC 847174 and CCDC 866232. CIF file containing complete information on the 
above structures are Freely available upon request from the following web site: www.ccdc.cam.ac.uk/data_request/cif. 
RESULT AND DISCUSSION 
Crystallography. The details of crystal data and refinements for 2a and 2b are given in Table 1. Table 2 gives their 








Fig. 2. View along the a axis of 2a (a) and c axis of 2b (b) showing C–H…O intermolecular interactions with 
dashed lines. H-atoms not involved in hydrogen bonding have been excluded. 
 
respectively. Fig. 2a and b show the hydrogen bond interactions in crystal structure of compounds 2a and 2b respectively. 
The compound 2a crystallizes in triclinic Pī space group with one molecule in the asymmetric unit. All bond 
distances and angles fall within the normal limits. In this compound the substituted aryl group at C5 chiral carbon atom of the 
thiazolopyrimidine ring is positioned axially [17], bisecting the dihydropyrimidine ring. The carboxylic acid ethyl ester and 
the methyl groups are attached on the either sides of the ring with trans configuration to the thiazolopyrimidine ring. All the 
atoms of the ethyl ester group at C6 is in the plane of the thiazolopyrimidine ring, whereas one of the atom (C13) of the ethyl 
ester group at C2 is deviating from the plane. The aryl ring is positioned almost orthogonal to thiazolopyrimidine ring with a 
dihedral angle of 88.64°, similar to those reported in the earlier structure [18]. The methoxy group on the aryl ring adopts 
anti-periplanar conformation with respect to C5–H5 bond. These features have been found mandatory for optimum calcium 
channel modulation activity from the recently proposed new binding-site model for this class of cardiovascular drugs [19]. In 
compound 2a, the central pyrimidine ring with a chiral C5 atom is significantly puckered and adopts a conformation which is 
best described as an intermediate between a boat and screw boat form similar to those reported earlier [20]. The plane 
calculation shows that the atoms C5 and N2 deviate from the mean plane N1/C7/C6/C21 constituting the ring by –0.331 Å 
and 0.026 Å respectively. The ring puckering parameters [21] for the pyrimidine ring are Q(2) = 0.246(3) Å, ϕ(2) = 7.5(7)° 
and θ = 114.3(7)° respectively. 
The crystal structure of compound 2a is stabilized by intermolecular C–H…O interactions. The C–H…O 
interactions forms two sets of centrosymmetric head to head and head to tail dimers with graph set motif 2
2
R (6) and 2
2
R (18) 
respectively along b axis. The molecular packing is further stabilized by π ring interactions of the type C–H…Cg1 (Cg1 being 
the centroid of the ring C14–C19) are also observed in the crystal structure; details are given the Table 2. 
In compound 2b the substituted aryl group at C5 chiral carbon atom of the thiazolopyrimidine ring is positioned 
pseudo axially to the dihydropyrimidine ring. The carboxylic acid ethyl ester and the methyl groups are attached on the either 
sides of the ring with trans configuration to the thiazolopyrimidine ring. The structural studies reveal that in contrast to 2a the 
C11 atom of the ethyl ester group at C6 is out of the plane of the thiazolopyrimidine ring, whereas the C18 atom of the ethyl 
ester group at C2 is slightly deviating from the plane. The aryl ring is almost orthogonal to thiazolopyrimidine ring with a 
dihedral angle of 84.88°. The survey of the structure at a molecular level reveals usual geometrical parameters for the S–C 
bond of 1.732(3) Å in the thiazolopyrimidine ring (aryl ring). In 2b, the central pyrimidine ring with a chiral C5 atom is 
significantly puckered and adopts the same conformation as described in case of 2a. The plane calculation shows that the 
atoms C5 and N2 deviate from the mean plane C8/N1/C6/C7 constituting the ring by 0.359 Å and 0.071 Å respectively. The 
ring puckering parameters [19] for the pyrimidine ring are Q(2) = 0.248(3) Å, ϕ(2) = 110.3(8)° and θ = 65.5(6)° respectively. 
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TABLE 1. Crystal Data and Structure Refinement of  2a and 2b 
Compound 2a 2b 
Empirical formula C21H24N2O5S C18H20N2O4S2 
Formula weight 416.48 392.48 
Temperature, K 296(2) 296 (2)  
Crystal system, space group Triclinic, P ī Triclinic, P ī 
Unit cell dimensions   
a, b, c, Å 7.747(3),  12.116(4),  12.533(4) 10.1202(8),  10.2565(7),  11.0240(9) 
α, β, γ, deg 64.903(6),  87.789(6),  75.878(6) 107.368(7),  113.290(7),  101.598(6) 
Volume, Å3 1030.3(6) 934.30(12) 
Z 2 2 
Calculated density, mg/cm3 1.343 1.395 
Absorption coefficient, mm–1 0.192 0.311 
F(000) 440 412 
θ range for data collection, deg. 2.72 to 27.00 2.35 to 27.00 
Limiting indices –9 ≤ h ≤ 9,  –14 ≤ k ≤ 15,  –15 ≤ l ≤ 15 –12 ≤ h ≤ 12,  –13 ≤ k ≤ 13,  –14 ≤ l ≤ 14 
Reflections collected / unique 6245 / 4347  [R(int) = 0.0244] 17963 / 4066  [R(int) = 0.0645] 
Completeness to θ, % 27.00  97.0 27.00  99.9 
Max. and min. transmission 0.9699 and 0.9662 0.9519 and 0.9462 
Data / restraints / parameters 4347 / 0 / 267 4066 / 0 / 239 
Goodness-of-fit on F 2 1.218 1.052 
wR2 [I > 2σ(I)] 0.1809 0.1698 
R indices (all data) R1 = 0.0940,  wR2 = 0.2374 R1 = 0.0850,  wR2 = 0.1922 
 
TABLE 2. C–H…π Interactions and Possible Hydrogen Bonds (Å, deg) for 2a and 2b (D – donor; A – acceptor; H – 
hydrogen) 
D–H⋯A D–H H⋯A D⋯A D–H⋯A D–H⋯A D–H H⋯A D⋯A D–H⋯A
2a 2b 
C4–H4C⋯O3i 0.960 2.718 3.671(5) 172 C4–H4A⋯O3i 0.960 2.733 3.644(5) 158 
C9–H9A⋯O1ii 0.970 2.872 3.699(5) 143 C11–H11C⋯O2ii 0.960  2.765 3.682(5) 160 




Symmetry code for 2a:  i –x + 1, –y, –z + 1;  ii –x + 1, –y, –z + 2; iii 1 – x, 1 – y, 1 – z.  
Symmetry code for 2b:  i –x, –y + 2, –z;  ii –x, –y + 1, –z – 1;  iii –x, –y, –z. 
 
The crystal structure of 2b is also stabilized by intermolecular C–H…O interactions. The C–H…O interactions 
forms centrosymmetric head-to-head and head-to-tail dimers with graph set motif 2
2
R (12) and 2
2
R (18), respectively, along c 
axis. In addition, π ring interactions of the type C–H…Cg2 (Cg2 being the centroid of the ring C12/C13/C14/C15/S2) are also 
observed in the crystal structure; details are given the Table 2. 
CONCLUSIONS 
Present work describes the synthesis of diester of thiazolopyrimidine derivatives which is a one step 
cyclocondensation reaction. The structural modifications in the pyrimidine moiety lead to improved biological properties. 
Crystals of the two compounds 2a and 2b were subjected to X-ray diffraction in order to get the blueprint of the molecules as 
well as the molecular structures. Additionally, the single crystal X-ray diffraction analysis revealed certain interesting 
features such as the aryl substitution at the C5 chiral carbon atom resulting in two different configurations. The crystal 
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structures of both compounds are stabilized by C–H…O interactions resulting in formation of centrosymmetric dimers. Apart 
from this other weak interaction such as C–H…π further stabilize the crystal structure. 
NSB is thankful to the University Grants Commission, Delhi, for the financial assistance. 
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